Cargando…
Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
In most cases, recurrent chronic colitis is caused by the recurrence of acute colitis after incomplete recovery and re-exposure to irritating factors, and the gut microbiome, which is the largest micro-ecosystem in the human body, plays a crucial role in the development of colitis. Plant polysacchar...
Autores principales: | Huang, Yichun, Zheng, Yinghui, Yang, Fengmei, Feng, Yicheng, Xu, Kunyao, Wu, Jun, Qu, Shuang, Yu, Zhexiong, Fan, Fu, Huang, Lu, Qin, Meng, He, Zhanlong, Nie, Kaili, So, Kwok-Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395742/ https://www.ncbi.nlm.nih.gov/pubmed/36017369 http://dx.doi.org/10.3389/fcimb.2022.921075 |
Ejemplares similares
-
Corrigendum: Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice
por: Huang, Yichun, et al.
Publicado: (2022) -
Effects of Lycium barbarum glycopeptide on renal and testicular injury induced by di(2-ethylhexyl) phthalate
por: Zhou, Xianling, et al.
Publicado: (2022) -
The Protective Effects of Lycium Barbarum Polysaccharides on Transient Retinal Ischemia
por: Yang, Di, et al.
Publicado: (2011) -
Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023) -
A Systematic Review of Potential Therapeutic Use of Lycium Barbarum Polysaccharides in Disease
por: Kwok, Sum Sum, et al.
Publicado: (2019)